Much is still to be learned about the molecular basis of mental disorders. The identification of a signalling pathway that is affected in schizophrenia, and which thus provides potential therapeutic targets, is a welcome advance.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Ross, C. A., Margolis, R. L., Reading, S. A., Pletnikov, M. & Coyle, J. T. Neuron 52, 139–153 (2006).
Lewis, D. A., Hashimoto, T. & Volk, D. W. Nature Rev. Neurosci. 6, 312–324 (2005).
Harrison, P. J. & Weinberger, D. R. Mol. Psychiatry 10, 40–68 (2005).
Camargo, L. M. et al. Mol. Psychiatry 12, 74–86 (2007).
Mao, Y. et al. Cell 136, 1017–1031 (2009).
Millar, J. K. et al. Hum. Mol. Genet. 9, 1415–1423 (2000).
Chubb, J. E. et al. Mol. Psychiatry 13, 36–64 (2008).
Kamiya, A. et al. Nature Cell Biol. 7, 1167–1178 (2005).
Sawa, A. & Snyder, S. H. Science 310, 1128–1129 (2005).
Duan, X. et al. Cell 130, 1146–1158 (2007).
Faulkner, R. L. et al. Proc. Natl Acad. Sci. USA 105, 14157–14162 (2008).
Lie, D. C. et al. Nature 437, 1370–1375 (2005).
Jope, R. S. & Roh, M. S. Curr. Drug Targets 7, 1421–1434 (2006).
Beaulieu, J. M., Gainetdinov, R. R. & Caron, M. G. Trends Pharmacol. Sci. 28, 166–172 (2007).
Scolnick, E. M. Biol. Psychiatry 59, 1039–1045 (2006).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Ross, C., Margolis, R. A point of disruption. Nature 458, 976–977 (2009). https://doi.org/10.1038/458976a
Published:
Issue Date:
DOI: https://doi.org/10.1038/458976a
This article is cited by
-
Neuregulin-1 signalling and antipsychotic treatment
Psychopharmacology (2013)
-
Co-ordinated action of DISC1, PDE4B and GSK3β in modulation of cAMP signalling
Molecular Psychiatry (2011)